Loading...
NPI 1235234402 · Farmingdale, NY · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Enzo Clinical Labs, Inc. is a clinical medical laboratory provider located in Farmingdale, New York. This profile covers 309 Medicare and 320 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Enzo Clinical Labs, Inc. |
| Address | 60 Executive Blvd |
| City | Farmingdale |
| State | NY |
| ZIP | 11735 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | September 13, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $26.2M |
| Medicare | $3.2M |
This provider is heavily Medicaid-focused by scale: Total Medicare revenue is $3.2M while Total Medicaid revenue is $26.2M, indicating Medicaid billing dominates this entity’s footprint and likely drives operational priorities and capacity decisions. The gap suggests the lab functions primarily as a high-volume Medicaid service provider rather than a Medicare-centric laboratory.
Revenue concentration differs by payer. Medicare is moderately concentrated with the precomputed top 3 codes accounting for 31.0% of Medicare revenue (the three highest Medicare codes are 84443, 80053, and 82306), while Medicaid is highly concentrated in a small set of codes with the precomputed top 3 accounting for 50.9% of Medicaid revenue (driven mainly by U0004, U0005, and 82306).
The mix of billed codes points to a broad clinical laboratory operation that combines routine chemistry/hematology panels (80053, 80061, 85025), endocrine and vitamin testing (84443, 82306, 82607), cytology services (88142, 88175, 88305), and extensive molecular/infectious disease testing (U0004, U0005, 87798, 87491, , ). This diversity indicates the lab provides both high-throughput pandemic-era testing and traditional diagnostic panels and cytopathology support to clinics and public health programs.
Medicare competitive standing is mixed: the facility posts sizable Medicare volumes for several common lab tests (for example 84443 ranks #106 of 19722 providers nationally and 80053 ranks #125 of 26416), which the source labels as typical or unremarkable national volumes for those codes. However, the provider is an outsized national performer on select services—88142 is flagged an "extreme outlier" and ranks #2 of 198 providers nationally—indicating a specialized strength in automated thin-layer cervical/vaginal cytology for Medicare.
On Medicaid in-state competition the lab is a major player for COVID testing and several high-volume diagnostics. U0004 accounts for $7.4M and 37.9% of the provider's Medicaid revenue and ranks #4 of 98 in-state (97th percentile; notably above typical state volume), and several STI and screening tests (87491, 87591, 87661) and routine panels (80061, 83036) rank in the top deciles in-state, reflecting dominant or near-dominant state-level throughput for those services.
The provider’s COVID-era testing footprint is pronounced across both payers: beyond U0004’s $7.4M Medicaid contribution, U0004 appears on Medicare with 765 claims and $56.6K revenue (2.6% of Medicare), and specimen-collection G2023 shows 66.4K claims and $332K revenue (1.7% of Medicaid) with a 99th in-state percentile. These figures point to substantial high-throughput SARS-CoV-2 testing and specimen logistics capability.
Cytology and certain specialty assays are statistical outliers for this lab across payers. 88142 is an "extreme outlier" nationally for Medicare (rank #2 of 198) and also ranks #4 of 172 in-state for Medicaid (1.8% of Medicaid revenue), while other tests such as 86141 and select HPV/cervical codes are described as "notably above typical" national or state volume — collectively indicating the lab has a pronounced niche in cervical cytology and related testing.
The provider has longstanding enrollment: NPI enumerated 2006-09-13 (~20 years ago). That tenure, combined with the high Medicaid volumes and concentrated COVID/molecular testing revenue, suggests an established regional operation with sustained contracts or referral relationships that support high sample throughput and specialized testing lines.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
309 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 14,270 | $20 | $228.3K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 22,320 | $10 | $223.2K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 7,650 | $30 | $221.7K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 16,360 | $10 | $212.6K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 20,740 | $10 | $165.9K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 15,380 | $10 | $123.1K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 10,700 | $10 | $107K |
| 82607 | The lab analyst performs a test to measure the amount of vitamin B12 in a patient specimen, typically in patient blood. | 5,560 | $20 | $83.4K |
| 84439 | The lab analyst performs a test to measure free thyroxine, or free T4, typically in patient serum. | 8,760 | $10 | $78.8K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 2,150 | $30 | $73K |
Showing 1–10 of 309
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 309 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
309 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 87798 | 12 | 40 | 740 | $30 | $218.3K |
| U0004 | 5 | 20 | 450 | $70 | $114.7K |
| G0480 | 26 | 30 | 170 | $110 | $76.5K |
| 88185 | 95 | 100 | 1,210 | $20 | $74.9K |
| 87581 | 5 | 10 | 350 | $30 | $64.6K |
| 87486 | 5 | 10 | 350 | $30 | $64.2K |
| 88305 | 448 | 980 | 370 | $50 | $58.5K |
| 87481 | 7 | 40 | 80 | $30 | $45.5K |
| 86235 | 14 | 40 | 650 | $20 | $33.6K |
| 86769 | 13 | 50 | 180 | $40 | $32.3K |
Showing 1–10 of 309
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
320 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 139,850 | $50 | $7.4M |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 76,630 | $20 | $1.5M |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 59,410 | $20 | $1.1M |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 75,530 | $10 | $1.1M |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 75,480 | $10 | $905.7K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 18,150 | $40 | $707.8K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 38,560 | $20 | $617K |
| 87624 | The lab analyst performs a test to determine the presence of human papillomavirus, or HPV. The provider uses nucleic acid detection for high–risk types and produces a pooled result. | 37,180 | $20 | $594.9K |
| 86480 | The lab analyst performs a test to evaluate a cell mediated immunity gamma interferon antigen response to certain tuberculosis, or TB, antibodies. | 15,490 | $30 | $511.1K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 82,230 | $10 | $493.4K |
Showing 1–10 of 320
How this provider's Medicaid billing volume and revenue compare to other New York providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. New York median
320 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 234 | 340 | 1,090 | $70 | $1.4M |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by… | 4 | 100 | 1,490 | $70 | $1.3M |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 38 | 140 | 360 | $130 | $492.1K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 15 | 300 | 1,710 | $20 | $458.6K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 64 | 290 | 1,900 | $30 | $390.6K |
| 81220 | The lab analyst performs the technical lab test to detect the presence of changes in the gene for cystic fibrosis transmembrane conductance regulator, also known as CFTR. The test evaluates the CFTR… | 8 | 60 | 230 | $370 | $340.9K |
| 81420 | The lab analyst performs a genomic sequence analysis panel to evaluate circulating cell free fetal DNA in maternal blood for genetic sequences of at least the genes on chromosomes 13, 18, and 21,… | 8 | 30 | 260 | $480 | $329.6K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 24 | 590 | 1,160 | $20 | $277.2K |
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 85 | 640 | 1,080 | $60 | $251.5K |
| 87536 | A lab tests a patient’s specimen to measure the amount of HIV–1 present. This may be referred to as viral load. | 61 | 80 | 1,280 | $80 | $225K |
Showing 1–10 of 320
Other providers in the same ZIP code as Enzo Clinical Labs, Inc., ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Optum Infusion Services 101, Inc. | NY | Home Infusion Therapy Pharmacy | $88.9K | $3.7M |
| Med-trans Corporation | NY | Air Ambulance | $468.1K | $1.8M |
| Progressive Surgery Center LLC | NY | Ambulatory Surgical Clinic/Center | $1.7M | $0 |
| Hasib Sarij | NY | Interventional Pain Medicine Physician | $597.8K | $404.6K |
| Ayesha Hameed | NY | Interventional Pain Medicine Physician | $431.5K | $7.5K |
| Ronald Fagan | NY | Internal Medicine Physician | $236.9K | $21.8K |
| Gil Martinez | NY | Physician Assistant | $256.7K | $0 |
| Jennifer Defeo | NY | Occupational Therapist | $205.3K | $0 |
| Greatneck Chemists Inc | NY | Long Term Care Pharmacy | $178.5K | $0 |
| Henry Purslow | NY | Physical Therapist | $157.9K | $0 |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.